Story

The Full Story

In four years Futu rewrote its own thesis. The company that listed in 2019 as a Tencent‑backed broker for affluent mainland Chinese was, by 2023, prohibited from onboarding those clients and pulled from China's app stores. Management's response — quiet on the loss, loud on the pivot — has been a methodical re‑plating of the same business onto Singapore, Malaysia, the U.S., Japan, Canada, Australia, and New Zealand, and onto two new product axes (crypto and AI) that didn't exist in the disclosures three years ago. The pivot has worked at the P&L level: revenue tripled and net income quadrupled between FY2021 and FY2025. But the credibility story is mixed — guidance has been beaten by 19–100% three years running, while the 2021 framing of the China business looks, in hindsight, less candid than what subsequent regulator action revealed.

1. The Narrative Arc

FY2021 Revenue (HK$M)

7,115

FY2025 Revenue (HK$M)

22,808

FY2021 Net Income (HK$M)

2,810

FY2025 Net Income (HK$M)

11,318
Loading...

The headline story is that the regulatory shock of 2022 caused no observable damage to the income statement. The narrative damage was substantially larger than the financial damage — and that is what the rest of this tab investigates.

Annotated timeline

No Results

2. What Management Emphasized — and Then Stopped Emphasizing

The clearest tell of a narrative pivot is what falls out of the press releases. Three things were once headline KPIs and are now gone: Stock Connect trading volume, DARTs as a featured operational bullet, and the running "X licenses" headline that peaked at "over 50" in FY2022 and was then quietly replaced by a list of countries.

Loading...

Read the heatmap as three movements. The diagonal of dropping intensity on the top three rows (mainland China, Stock Connect, Hong Kong dominance) is the regulatory pivot. The diagonal of rising intensity on the bottom four (Japan/Canada/Malaysia/NZ, US, crypto, AI) is the new growth thesis. Wealth management quietly went from a footnote to a 5 across the back half — the AUM line moved from HK$43.5B in Q2 FY2023 to HK$179.6B in Q4 FY2025, a 4× rise in 11 quarters.

3. Risk Evolution

The 20‑F risk factors track three different stories at once. The mainland China risk lifecycle goes from soft‑hypothetical (FY2021) → fully articulated (FY2022) → factual ("apps removed May 19, 2023" in FY2023) → stable plateau. The HFCAA / PCAOB delisting risk runs the opposite direction: present‑tense in FY2021, deflated to a hypothetical conditional by FY2025. And a third group — virtual assets, AI, single‑borrower stock‑pledged loan concentration, and Trump‑era tariffs — appears from nothing.

Loading...

The single most important refinement in the FY2024–FY2025 risk factors is one easy to miss: the disclosure that a single borrower accounted for 95.91% of total stock‑pledged loans at FY2024 year‑end, rising to 95.99% at FY2025. With outstanding loans and advances growing from HK$32.5bn (FY2023) to HK$64.7bn (FY2025), this is the most material single counterparty exposure in the company today and it landed in the disclosures only after Hong Kong's 2024 stock‑pledged blow‑ups forced sharper language.

4. How They Handled Bad News

The mainland China question is the test case. In late 2021 management could have signalled to investors that the regulatory wind was shifting; instead, when Reuters reported (December 17, 2021) that a ban was coming, the company's response was to say it "has not received any formal orders along the lines of those suggested by Reuters reporting." Twelve months later, the CSRC issued exactly that order.

The contrast with Q4 FY2025 is instructive. When growth in Hong Kong decelerated and the FY2026 funded‑account guide was held flat at 800,000 — the first non‑raise after three guidance years — the language was direct: "Growth in Hong Kong decelerated quarter‑over‑quarter due to a sharp Hong Kong stock market downturn." No euphemism, no deflection. On crypto, where Q4 sentiment turned, management used a defensive but honest framing — "Despite weak sentiment in crypto in the fourth quarter, crypto trading volume remained resilient." That is the modern Futu communications voice — straight reporting, no surprises.

5. Guidance Track Record

Annual paying‑client (now funded‑account) guidance has been the company's most public commitment device. The FY2024 cycle was raised twice and still beaten by 28%; the FY2025 cycle was beaten by 19%; the FY2026 guide is flat to FY2025 actual delivery — a sharp tonal shift after a three‑year run of beats.

No Results
Loading...

Other documented commitments and their fates:

No Results

Credibility Score

6.5

out of 10

Why 6.5/10. Three recent years of meeting or exceeding stated targets — paying‑client guidance, market‑entry timing, capital‑return execution — pull the score up. The 2021 framing of the mainland China risk is what holds it back: the legal claim was dismissed, but the gap between management's "no formal orders" framing and what regulators delivered twelve months later is on record. The Q4 FY2025 language, where deceleration was acknowledged plainly rather than dressed up, is the more reliable read of the current management voice.

6. What the Story Is Now

The current Futu pitch has three legs that did not exist in 2021. First, internationalization is real: more than half of funded accounts are now outside Hong Kong, with Singapore as a fortress, Malaysia as the fastest scaler, Japan recovering after a 2024 wobble, and the U.S. retail business now visibly contributing to net‑asset inflow. Second, virtual assets are no longer a market driver — they are a Futu product line: HK + SG since August 2024, U.S. live since June 2025, crypto trading volume +161% QoQ in Q3 FY2025, a tokenized money‑market fund with ChinaAMC, and a Hong Kong VATP license through Panthertrade. Third, AI moved from market‑color in trading commentary to a recurring R&D cost driver: Futubull AI launched Q1 FY2025, Moomoo AI extended into Malay-language coverage by Q3 FY2025, and "investment in AI capabilities" is now the standing explanation for R&D growth.

What the reader should believe: the international and product diversification is genuine and is reflected in P&L and AUM lines, not just in the press releases. Wealth management AUM at HK$179.6B in Q4 FY2025 versus HK$43.5B in Q2 FY2023 is the single hardest data point against the "still a Hong Kong margin shop" critique.

What the reader should discount: the framing that the China onboarding loss was a discrete event from which the company has fully moved on. The reason that line is still in the FY2025 risk factors — with the new "jointly with other authorities" phrasing — is that the regulator has not closed the file. The company has out‑grown the headline, not the residual exposure.